Search - tctmd.com

Displaying 781 - 800 of 818

Sort: Relevancy | Date

Presentation TCT 2012

Epicardial LAA Closure with the LARIAT (SentreHEART): Simple, Safe, and Effective?

Presenter: Mark Reisman

October 23, 2012

News Industry News

Boston Scientific Demonstrates Ongoing Structural Heart Advances at Transcatheter Cardiovascular Therapeutics 2012 in Miami

October 23, 2012

Presentation TCT 2012

A Primer of LAA Closure Imaging: Essential Views and Pattern Recognition

Presenter: Rebecca Hahn

October 23, 2012

Presentation TCT 2012

Specialized Structural Interventions: Approaches to HOCM, Paravalvular Leak, Acute MI VSD, and LAA Closure

Presenter: Robert Sommer

October 22, 2012

Presentation TCT 2012

LAA Closure Devices

Presenter: Russell Brandwein

October 22, 2012

News Daily News

Un Nuevo Dispositivo Resulta Prometedor para el Cierre Seguro y Eficaz del AAI

Yael L. Maxwell

October 12, 2012

News Daily News

Novel Device Shows Promise for Safe, Effective LAA Closure

Yael L. Maxwell

October 12, 2012

News Daily News

Watchman Device for LAA Closure Provides Net Clinical Benefit vs. Warfarin in A-fib Patients

September 27, 2012

News Daily News

El Dispositivo Watchman para el Cierre del AAI Ofrece Beneficios Clínicos Netos comparado con la Warfarina en Pacientes con FA

September 27, 2012

Presentation

Percutaneous LAA Closure for Stroke Prevention in A-fib Patients: An Assessment of Net Clinical Benefit

Presenter: S.R. Gangireddy

September 26, 2012

News Conference News ESC 2012

ESC Congress 2012 Offers Slate of Guidelines, New MI Definition

Caitlin E. Cox

August 26, 2012

News Industry News

Boston Scientific WATCHMAN® Left Atrial Appendage Closure Device Receives CE Mark Approval For Expanded Use

August 26, 2012

News Daily News

Survey Reflects US Structural Intervention Training in Its ‘Infancy’

Jason Kahn

July 31, 2012

News Daily News

Left Atrial Appendage Morphology May Help Predict Stroke Risk in A-fib Patients

July 31, 2012

News Industry News

Boston Scientific Completes Patient Enrollment in PREVAIL Study for First-in-Class WATCHMAN Device

July 02, 2012

Presentation TVT 2012

Outcomes of Surgical LAA Closure

Presenter: Ted Feldman

June 04, 2012

Presentation

Watchman LAA Closure in A-fib Patients with Contraindication to Oral Anticoagulation

Presenter: Vivek Y. Reddy

May 30, 2012

News Industry News

Key Clinical Data for St. Jude Medical’s Structural Heart Technologies Revealed at EuroPCR

May 16, 2012

News Industry News

Study of First-in-Class WATCHMAN® Device Shows 75 Percent Reduction in Stroke Risk in Patients with Atrial Fibrillation Not Eligible for Oral Anticoagulation Therapy

May 11, 2012

News Daily News

Lack of Complete Seal with Watchman Device Common, But No Cause for Alarm

Jason Kahn

March 05, 2012

Advertisement

Epicardial LAA Closure with the LARIAT (SentreHEART): Simple, Safe, and Effective?

Boston Scientific Demonstrates Ongoing Structural Heart Advances at Transcatheter Cardiovascular Therapeutics 2012 in Miami

A Primer of LAA Closure Imaging: Essential Views and Pattern Recognition

Specialized Structural Interventions: Approaches to HOCM, Paravalvular Leak, Acute MI VSD, and LAA Closure

LAA Closure Devices

Un Nuevo Dispositivo Resulta Prometedor para el Cierre Seguro y Eficaz del AAI

Novel Device Shows Promise for Safe, Effective LAA Closure

Watchman Device for LAA Closure Provides Net Clinical Benefit vs. Warfarin in A-fib Patients

El Dispositivo Watchman para el Cierre del AAI Ofrece Beneficios Clínicos Netos comparado con la Warfarina en Pacientes con FA

Percutaneous LAA Closure for Stroke Prevention in A-fib Patients: An Assessment of Net Clinical Benefit

ESC Congress 2012 Offers Slate of Guidelines, New MI Definition

Boston Scientific WATCHMAN® Left Atrial Appendage Closure Device Receives CE Mark Approval For Expanded Use

Survey Reflects US Structural Intervention Training in Its ‘Infancy’

Left Atrial Appendage Morphology May Help Predict Stroke Risk in A-fib Patients

Boston Scientific Completes Patient Enrollment in PREVAIL Study for First-in-Class WATCHMAN Device

Outcomes of Surgical LAA Closure

Watchman LAA Closure in A-fib Patients with Contraindication to Oral Anticoagulation

Key Clinical Data for St. Jude Medical’s Structural Heart Technologies Revealed at EuroPCR

Study of First-in-Class WATCHMAN® Device Shows 75 Percent Reduction in Stroke Risk in Patients with Atrial Fibrillation Not Eligible for Oral Anticoagulation Therapy

Lack of Complete Seal with Watchman Device Common, But No Cause for Alarm

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content